vs
艾伯维（ARGX）与罗致恒富（RHI）财务数据对比。点击上方公司名可切换其他公司
艾伯维的季度营收约是罗致恒富的1.9倍（$2.5B vs $1.3B），艾伯维同比增速更快（83.2% vs -5.8%），艾伯维自由现金流更多（$322.4M vs $170.8M）
艾伯维是总部位于美国伊利诺伊州北芝加哥的制药企业，研发生产的药物覆盖多种疾病治疗领域，可满足多元临床需求，致力于为全球不同病症的患者提供可靠的治疗方案选择。
罗致恒富是1948年成立的国际人力资源咨询机构，总部位于加利福尼亚州门洛帕克和圣拉蒙，是全球规模领先的会计与金融领域人才派遣服务商之一，在全球范围内设有超过345个办公点。
ARGX vs RHI — 直观对比
营收规模更大
ARGX
是对方的1.9倍
$1.3B
营收增速更快
ARGX
高出89.0%
-5.8%
自由现金流更多
ARGX
多$151.6M
$170.8M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.5B | $1.3B |
| 净利润 | $877.2M | — |
| 毛利率 | 89.5% | 37.6% |
| 营业利润率 | 28.9% | 1.7% |
| 净利率 | 35.5% | — |
| 营收同比 | 83.2% | -5.8% |
| 净利润同比 | 1.3% | — |
| 每股收益（稀释后） | $13.25 | $0.32 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARGXRHI
| Q4 25 | $2.5B | $1.3B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | $1.8B | $1.4B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | $1.4B | $1.4B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $901.9M | $1.5B | ||
| Q1 24 | — | $1.5B |
净利润ARGXRHI
| Q4 25 | $877.2M | — | ||
| Q3 25 | — | $42.9M | ||
| Q2 25 | $414.8M | $41.0M | ||
| Q1 25 | — | $17.4M | ||
| Q4 24 | $865.6M | — | ||
| Q3 24 | — | $65.5M | ||
| Q2 24 | $-32.5M | $68.2M | ||
| Q1 24 | — | $63.7M |
毛利率ARGXRHI
| Q4 25 | 89.5% | 37.6% | ||
| Q3 25 | — | 37.2% | ||
| Q2 25 | 89.2% | 37.2% | ||
| Q1 25 | — | 36.9% | ||
| Q4 24 | 90.2% | 38.8% | ||
| Q3 24 | — | 39.0% | ||
| Q2 24 | 89.4% | 39.2% | ||
| Q1 24 | — | 38.1% |
营业利润率ARGXRHI
| Q4 25 | 28.9% | 1.7% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | 19.2% | 0.1% | ||
| Q1 25 | — | 2.9% | ||
| Q4 24 | 8.7% | 4.7% | ||
| Q3 24 | — | 4.1% | ||
| Q2 24 | -15.4% | 5.1% | ||
| Q1 24 | — | 2.8% |
净利率ARGXRHI
| Q4 25 | 35.5% | — | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | 23.4% | 3.0% | ||
| Q1 25 | — | 1.3% | ||
| Q4 24 | 64.1% | — | ||
| Q3 24 | — | 4.5% | ||
| Q2 24 | -3.6% | 4.6% | ||
| Q1 24 | — | 4.3% |
每股收益（稀释后）ARGXRHI
| Q4 25 | $13.25 | $0.32 | ||
| Q3 25 | — | $0.43 | ||
| Q2 25 | $6.32 | $0.41 | ||
| Q1 25 | — | $0.17 | ||
| Q4 24 | $13.33 | $0.53 | ||
| Q3 24 | — | $0.64 | ||
| Q2 24 | $-0.55 | $0.66 | ||
| Q1 24 | — | $0.61 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.5B | $464.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $7.3B | $1.3B |
| 总资产 | $8.7B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ARGXRHI
| Q4 25 | $3.5B | $464.4M | ||
| Q3 25 | — | $365.3M | ||
| Q2 25 | $2.1B | $380.5M | ||
| Q1 25 | — | $342.5M | ||
| Q4 24 | $1.5B | $537.6M | ||
| Q3 24 | — | $570.5M | ||
| Q2 24 | $1.4B | $547.4M | ||
| Q1 24 | — | $540.9M |
总债务ARGXRHI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $11.0M | — | ||
| Q1 24 | — | — |
股东权益ARGXRHI
| Q4 25 | $7.3B | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | $6.1B | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | $5.5B | $1.4B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | $4.3B | $1.5B | ||
| Q1 24 | — | $1.5B |
总资产ARGXRHI
| Q4 25 | $8.7B | $2.9B | ||
| Q3 25 | — | $2.8B | ||
| Q2 25 | $7.2B | $2.8B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | $6.2B | $2.9B | ||
| Q3 24 | — | $3.0B | ||
| Q2 24 | $4.8B | $2.9B | ||
| Q1 24 | — | $2.9B |
负债/权益比ARGXRHI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $323.3M | $182.5M |
| 自由现金流经营现金流 - 资本支出 | $322.4M | $170.8M |
| 自由现金流率自由现金流/营收 | 13.0% | 13.1% |
| 资本支出强度资本支出/营收 | 0.0% | 0.9% |
| 现金转化率经营现金流/净利润 | 0.37× | — |
| 过去12个月自由现金流最近4个季度 | $594.5M | $266.8M |
8季度趋势，按日历期对齐
经营现金流ARGXRHI
| Q4 25 | $323.3M | $182.5M | ||
| Q3 25 | — | $77.4M | ||
| Q2 25 | $361.8M | $119.4M | ||
| Q1 25 | — | $-59.3M | ||
| Q4 24 | $41.9M | $154.8M | ||
| Q3 24 | — | $129.6M | ||
| Q2 24 | $-124.7M | $142.0M | ||
| Q1 24 | — | $-15.9M |
自由现金流ARGXRHI
| Q4 25 | $322.4M | $170.8M | ||
| Q3 25 | — | $63.6M | ||
| Q2 25 | $356.6M | $104.2M | ||
| Q1 25 | — | $-71.7M | ||
| Q4 24 | $40.9M | $140.5M | ||
| Q3 24 | — | $111.8M | ||
| Q2 24 | $-125.5M | $129.6M | ||
| Q1 24 | — | $-27.7M |
自由现金流率ARGXRHI
| Q4 25 | 13.0% | 13.1% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | 20.1% | 7.6% | ||
| Q1 25 | — | -5.3% | ||
| Q4 24 | 3.0% | 10.2% | ||
| Q3 24 | — | 7.6% | ||
| Q2 24 | -13.9% | 8.8% | ||
| Q1 24 | — | -1.9% |
资本支出强度ARGXRHI
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | 0.3% | 1.1% | ||
| Q1 25 | — | 0.9% | ||
| Q4 24 | 0.1% | 1.0% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | 0.1% | 0.8% | ||
| Q1 24 | — | 0.8% |
现金转化率ARGXRHI
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | 1.80× | ||
| Q2 25 | 0.87× | 2.91× | ||
| Q1 25 | — | -3.42× | ||
| Q4 24 | 0.05× | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.08× | ||
| Q1 24 | — | -0.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARGX
暂无分部数据
RHI
| Finance And Accounting | $535.2M | 41% |
| Protiviti | $479.0M | 37% |
| Technology | $156.4M | 12% |
| Permanent Placement Talent Solutions | $102.6M | 8% |
| Other | $29.2M | 2% |
